MediWound (MDWD) Return on Capital Employed (2016 - 2026)
MediWound (MDWD) posted quarterly Return on Capital Employed of 39.09% for Q4 2025, up 169.0% year-over-year from 14.53% in Q4 2024, and up 9.67% quarter-over-quarter from 43.28% in Q3 2025.
MediWound (MDWD) Return on Capital Employed (2016 - 2026) Analysis & Trends
MediWound's Return on Capital Employed history runs 10 years deep, the most recent figure standing at 39.09% for Q4 2025.
- In Q4 2025, Return on Capital Employed rose 169.0% year-over-year to 39.09%; the TTM figure through Dec 2025 stood at 39.09% (up 169.0% YoY), while the FY2025 annual figure was 46.64%, down 198.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 39.09%, up from 43.28% in the prior quarter.
- The five-year high for Return on Capital Employed was 19.18% in Q3 2023, with the low at 106.59% in Q1 2022.
- The 5-year median for Return on Capital Employed is 42.4% (2025), against an average of 51.35%.
- The sharpest annual moves came in 2021 and 2023: Return on Capital Employed sank 6908 bps in 2021, then jumped 8021 bps in 2023.
- MediWound's Return on Capital Employed stood at 104.54% in 2021, then surged by 71 bps to 30.63% in 2022, then dropped by 3 bps to 31.45% in 2023, then retreated by 30 bps to 40.78% in 2024, then rose by 4 bps to 39.09% in 2025.
- Business Quant data shows MDWD's Return on Capital Employed at 39.09% in Q4 2025, 43.28% in Q3 2025, and 56.82% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -38.20% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 26.09% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -6.85% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -50.93% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 7.88% |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | -48.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -48.74% |
| Dec 31, 2025 | -39.09% |
| Sep 30, 2025 | -43.28% |
| Jun 30, 2025 | -56.82% |
| Mar 31, 2025 | -42.28% |
| Dec 31, 2024 | -40.78% |
| Sep 30, 2024 | -42.52% |
| Jun 30, 2024 | -40.66% |
| Mar 31, 2024 | -34.84% |
| Dec 31, 2023 | -31.45% |
| Sep 30, 2023 | -19.18% |
| Jun 30, 2023 | -20.11% |
| Mar 31, 2023 | -26.62% |
| Dec 31, 2022 | -30.63% |
| Sep 30, 2022 | -88.35% |
| Jun 30, 2022 | -100.32% |
| Mar 31, 2022 | -106.59% |
| Dec 31, 2021 | -104.54% |
| Sep 30, 2021 | -68.50% |
| Jun 30, 2021 | -47.81% |